QuidelOrtho Corporation (QDEL) Revenue History
QuidelOrtho Corporation (QDEL) annual revenue history. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2022-12-31 | $3.27B |
| 2023-12-31 | $3.00B |
| 2024-12-31 | $2.78B |
| 2025-12-31 | $2.73B |
How QDEL compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| NBIX | Neurocrine Biosciences Inc. | $2.86B |
| NVST | Envista Holdings Corporation | $2.72B |
| PODD | Insulet Corporation | $2.71B |
| BIO | Bio-Rad Laboratories Inc. Class A | $2.58B |
| EXEL | Exelixis Inc. | $2.32B |
These are five companies in the same sector as QDEL with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get QuidelOrtho Corporation Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("QDEL", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | QDEL | $14.74 | -0.74% | 2.02M |
| 3 | ||||
| 4 | ||||
| 5 |